Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ALEXANDER PUSHKA

Allopathic & Osteopathic Physicians Psychiatry & Neurology Child & Adolescent Psychiatry

NPI
1992793384
CMS profile
448474
Location
HOLLYWOOD, FL

General Payments · PY2018–2024

$4,195.37

  • Reported across 166 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,333.48

55 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,333.48 55

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $164.52 5
PY2019 $268.24 5
PY2020 $50.62 2
PY2021 $558.59 16
PY2022 $549.72 25
PY2023 $1,270.20 58
PY2024 $1,333.48 55

Payment records · PY2024 (55)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $21.84 08/09/2024 Food and Beverage Undisputed 01/23/2026 1105328592 CMS
Almatica Pharma LLC $16.31 05/09/2024 Food and Beverage Undisputed 01/23/2026 1137575424 CMS
Almatica Pharma LLC $0.75 05/09/2024 Food and Beverage Undisputed 01/23/2026 1137575429 CMS
Almatica Pharma LLC $17.79 08/12/2024 Food and Beverage Undisputed 01/23/2026 1137575433 CMS
Almatica Pharma LLC $25.71 09/29/2024 Food and Beverage Undisputed 01/23/2026 1137575437 CMS
Almatica Pharma LLC $27.47 10/21/2024 Food and Beverage Undisputed 01/23/2026 1137575442 CMS
Almatica Pharma LLC $18.98 11/04/2024 Food and Beverage Undisputed 01/23/2026 1137575446 CMS
Almatica Pharma LLC $1.86 11/04/2024 Food and Beverage Undisputed 01/23/2026 1137575451 CMS
Almatica Pharma LLC $22.32 12/19/2024 Food and Beverage Undisputed 01/23/2026 1137575455 CMS
Axsome Therapeutics, Inc. $11.37 02/14/2024 Food and Beverage Undisputed 01/23/2026 1148262487 CMS
Axsome Therapeutics, Inc. $27.51 03/08/2024 Food and Beverage Undisputed 01/23/2026 1148262489 CMS
Axsome Therapeutics, Inc. $25.59 04/11/2024 Food and Beverage Undisputed 01/23/2026 1148262493 CMS
Axsome Therapeutics, Inc. $30.62 05/02/2024 Food and Beverage Undisputed 01/23/2026 1148262491 CMS
Axsome Therapeutics, Inc. $33.50 05/30/2024 Food and Beverage Undisputed 01/23/2026 1148262495 CMS
Axsome Therapeutics, Inc. $14.58 06/07/2024 Food and Beverage Undisputed 01/23/2026 1148262497 CMS
Axsome Therapeutics, Inc. $23.55 11/26/2024 Food and Beverage Undisputed 01/23/2026 1148262499 CMS
Indivior Inc. $28.16 02/29/2024 Food and Beverage Undisputed 01/23/2026 1144535915 CMS
Indivior Inc. $26.04 03/04/2024 Food and Beverage Undisputed 01/23/2026 1144535917 CMS
Indivior Inc. $28.47 06/03/2024 Food and Beverage Undisputed 01/23/2026 1144535919 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.85 01/08/2024 Food and Beverage Undisputed 01/23/2026 1143299993 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.99 01/25/2024 Food and Beverage Undisputed 01/23/2026 1143299996 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.28 02/26/2024 Food and Beverage Undisputed 01/23/2026 1143300000 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $1.56 02/27/2024 Food and Beverage Undisputed 01/23/2026 1143300004 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $2.10 02/27/2024 Food and Beverage Undisputed 01/23/2026 1143300008 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $0.97 02/27/2024 Food and Beverage Undisputed 01/23/2026 1143300011 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.33 05/16/2024 Food and Beverage Undisputed 01/23/2026 1143300015 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.64 06/20/2024 Food and Beverage Undisputed 01/23/2026 1143300019 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.54 07/25/2024 Food and Beverage Undisputed 01/23/2026 1143300023 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.93 07/30/2024 Food and Beverage Undisputed 01/23/2026 1143300026 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $25.87 09/05/2024 Food and Beverage Undisputed 01/23/2026 1143300030 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $25.71 09/18/2024 Food and Beverage Undisputed 01/23/2026 1143300034 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.24 10/08/2024 Food and Beverage Undisputed 01/23/2026 1143300037 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $25.56 11/21/2024 Food and Beverage Undisputed 01/23/2026 1143300041 CMS
Janssen Pharmaceuticals, Inc $15.41 01/22/2024 Food and Beverage Undisputed 01/23/2026 1077961698 CMS
Janssen Pharmaceuticals, Inc $15.40 02/26/2024 Food and Beverage Undisputed 01/23/2026 1077962054 CMS
Janssen Pharmaceuticals, Inc $11.98 03/25/2024 Food and Beverage Undisputed 01/23/2026 1077961950 CMS
Janssen Pharmaceuticals, Inc $24.61 04/25/2024 Food and Beverage Undisputed 01/23/2026 1077962074 CMS
Janssen Pharmaceuticals, Inc $16.87 05/30/2024 Food and Beverage Undisputed 01/23/2026 1077961708 CMS
Janssen Pharmaceuticals, Inc $24.18 07/11/2024 Food and Beverage Undisputed 01/23/2026 1077961822 CMS
Janssen Pharmaceuticals, Inc $149.92 10/10/2024 Food and Beverage Undisputed 01/23/2026 1077961858 CMS
Janssen Pharmaceuticals, Inc $16.07 10/30/2024 Food and Beverage Undisputed 01/23/2026 1077961696 CMS
Janssen Pharmaceuticals, Inc $17.92 12/05/2024 Food and Beverage Undisputed 01/23/2026 1077961740 CMS
Lundbeck LLC $23.69 10/18/2024 Food and Beverage Undisputed 01/23/2026 1145958360 CMS
Neos Therapeutics, LP $21.64 03/19/2024 Food and Beverage Undisputed 01/23/2026 1082674669 CMS
Neos Therapeutics, LP $23.62 04/09/2024 Food and Beverage Undisputed 01/23/2026 1082664577 CMS
Neurocrine Biosciences, Inc. $28.61 02/05/2024 Food and Beverage Undisputed 01/23/2026 1150829296 CMS
Neurocrine Biosciences, Inc. $31.12 04/26/2024 Food and Beverage Undisputed 01/23/2026 1150824168 CMS
Neurocrine Biosciences, Inc. $38.48 06/11/2024 Food and Beverage Undisputed 01/23/2026 1150816002 CMS
Neurocrine Biosciences, Inc. $30.00 08/14/2024 Food and Beverage Undisputed 01/23/2026 1150825940 CMS
Neurocrine Biosciences, Inc. $35.38 10/21/2024 Food and Beverage Undisputed 01/23/2026 1150818596 CMS
Neurocrine Biosciences, Inc. $39.85 12/12/2024 Food and Beverage Undisputed 01/23/2026 1150814922 CMS
Otsuka America Pharmaceutical, Inc. $21.92 12/04/2024 Food and Beverage Undisputed 01/23/2026 1118964405 CMS
Teva Pharmaceuticals USA, Inc. $34.79 04/08/2024 Food and Beverage Undisputed 01/23/2026 1151706644 CMS
Tris Pharma Inc $24.93 04/22/2024 Food and Beverage Undisputed 01/23/2026 1147207945 CMS
Tris Pharma Inc $24.10 05/06/2024 Food and Beverage Undisputed 01/23/2026 1147207943 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.